|
BioBos Respi 4
|
-
|
V/I/25/0039
|
Bioveta, a.s., Čehija
|
QI02AL
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bovine respiratory syncytial virus, strain BIO-24,Inactivated bovine parainfluenza-3 virus, strain BIO-23,Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1,Inactivated bovine viral diarrhea virus, strain BIO-25
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
30-May-2025
|
| Marketing authorisation valid until: |
29-May-2030
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 30052025 (21-Aug-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/25/0039-01 |
|
1 |
Plastmasas flakons, 5 deva |
[PDF]
[PDF]
|
| V/I/25/0039-02 |
|
1 |
Stikla flakons, 5 deva |
[PDF]
[PDF]
|
| V/I/25/0039-03 |
|
1 |
Plastmasas flakons, 25 deva |
[PDF]
[PDF]
|
| V/I/25/0039-04 |
|
1 |
Stikla flakons, 25 deva |
[PDF]
[PDF]
|
|
|
INTRAMAR Lacto 200 mg + 50 mg + 10 mg
|
-
|
V/I/26/0031
|
Bioveta a.s., Čehija
|
QJ51RV01
|
cattle (lactating cows)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
12-Jun-2026
|
| Marketing authorisation valid until: |
11-Jun-2031
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 17062026LI (17-Jun-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/26/0031-01 |
|
24 |
Injektors, 4,5 ml |
-
|
|
|
UBAC
|
deva
|
EU/2/18/227/003
|
Laboratorios Hipra S.A., Spānija
|
QI02AB
|
cattle (calf)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Streptococcus uberis
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
26-May-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/227/003 |
25 deva |
1 |
PET pudele, 50 ml |
-
|
|
|
Lotilaner/Milbemycin Elanco 450 mg/16,88 mg
|
-
|
EU/2/26/361/015
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/015 |
|
6 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Porcilis PCV M Hyo
|
-
|
EU/2/14/175/010
|
Intervet International B.V., Nīderlande
|
QI09AL
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae,Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
30-Nov-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/175/010 |
|
10 |
PET pudele, 250 deva |
-
|
|
|
Startvac
|
-
|
EU/2/08/092/006
|
Laboratorios Hipra S.A., Spānija
|
QI02AB
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Staphylococcus aureus,Inactivated Escherichia coli
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
13-Feb-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/092/006 |
|
1 |
Stikla pudelīte, 25 deva |
-
|
|
|
Rheumocam
|
0.5 mg/ml
|
EU/2/07/078/022
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
18-Dec-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/078/022 |
10 ml |
1 |
Flakons, 10 ml |
-
|
|
|
Circovac
|
-
|
EU/2/07/075/001
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
MERIAL Laboratoire Porte des Alpes, Francija;Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
21-Jun-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/075/001 |
|
1 |
Stikla flakons, 10 ml |
-
|
|
|
Versican Plus DHPPi/L4R
|
-
|
EU/2/14/163/002
|
Zoetis Belgium S.A., Beļģija
|
QI07AJ06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Canine Parainfluenza Type 2 virus, strain CPiV2-Bio15,Inactivated rabies virus, strain SAD Vnukovo-32,Canine Distemper virus, strain CDV Bio 11/A,Canine Adenovirus Type 2, strain CAV2-Bio 13,Canine Parvovirus Type 2, strain CPV-2b-Bio 12/B,Inactivated Leptospira interrogans serovar Canicola, strain MSLB 1090,Leptospira kirschneri serovar Grippotyphosa, strain MSLB 1091,Leptospira interrogans serovar Bratislava, strain MSLB 1088,Leptospira interrogans serovar Icterohaemorrhagia, strain MSLB 1089
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
09-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/163/002 |
|
50 |
Stikla flakons, 1 deva |
-
|
|
|
Vectra 3D
|
-
|
EU/2/13/156/015
|
Ceva Sante Animale, Francija
|
QP53AC54
|
medium dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Permethrin,Pyriproxyfen,Dinotefuran
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
27-Aug-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/156/015 |
|
48 |
Pipete, 1 deva |
-
|
|
|
Purevax RCP
|
-
|
EU/2/04/052/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AH09
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Live attenuated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial Laboratory of Lyon Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
25-Jan-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| -01 |
1 devas/flakonā |
10 |
Pudele, 1 deva |
-
|
|
|
ArthriCox
|
227 mg
|
EU/2/24/323/003
|
Chanelle Pharmaceuticals Manufacturing Limited, Īrija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Oct-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/323/003 |
227 mg |
30 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Bovela
|
-
|
EU/2/14/176/009
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI02AD02
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health USA Inc., ASV
|
| Date of authorisation/renewal: |
21-Dec-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
[PDF] 180917LI (18-Sep-2017)
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/176/009 |
|
1 |
Stikla flakons, 25 deva |
-
|
|
|
Loxicom
|
20 mg/ml
|
EU/2/08/090/013
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/013 |
20 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
Activyl
|
195 mg/ml
|
EU/2/10/118/016
|
Intervet International B.V., Nīderlande
|
QP53AX27
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Indoxacarb
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Intervet Productions S.A., Francija
|
| Date of authorisation/renewal: |
07-Jan-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/118/016 |
195 mg/ml |
6 |
Pipete, 0,71 ml |
-
|
|
|
Stronghold
|
30 mg
|
EU/2/99/014/003
|
Zoetis Belgium S.A., Beļģija
|
QP54AA05
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Service Company bvba, Beļģija
|
| Date of authorisation/renewal: |
01-Oct-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/014/003 |
30 mg/deva |
3 |
Polipropilēna tūbiņa, 1 deva |
-
|
|
|
Prevestrus vet
|
100 mg/tabl.
|
EU/2/25/338/010
|
Vetcare Oy, Somija
|
-
|
dogs (bitches)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Finrozole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Apr-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/338/010 |
|
1 |
Blisteris, 14 tablete |
-
|
|
|
Lotilaner/Milbemycin Elanco 56,25 mg/2,11 mg
|
-
|
EU/2/26/361/003
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/003 |
|
6 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Virbagen Omega
|
10 MU
|
EU/2/01/030/004
|
Virbac S.A., Francija
|
QL03AB
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Recombinant Omega interferon of feline origin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
20-Nov-2006
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/01/030/004 |
10 MU |
1 |
Flakons, 1 flakons |
-
|
|
|
Emdocam
|
20 mg/ml
|
EU/2/11/128/002
|
Emdoka bvba, Beļģija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
21-Jun-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/128/002 |
20 mg/ml |
1 |
Pudelīte (caurspīdīga), 100 ml |
-
|
|